Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Samuel Agresta currently holds 110,000 shares of Foghorn Therapeutics Inc. (FHTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Samuel Agresta has been a net seller of FHTX stock. They have purchased $0 and sold $2.6M worth of shares.
Samuel Agresta's most recent insider trade was on Apr 1, 2026, when they sold 110,000 shares at $0.00 per share.
Samuel Agresta serves as Executive at Foghorn Therapeutics Inc. (FHTX). They have executed 5 insider transactions totaling $2.6M over their tenure at the company.
Samuel Agresta holds the position of Executive at Foghorn Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Samuel Agresta has shown a selling trading pattern, with $0 in total purchases and $2.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Samuel Agresta was on Aug 16, 2023, when they sold $2.6M worth of FHTX shares. This transaction involved 311,297 shares at $8.25 per share.
Samuel Agresta currently owns 110,000 shares of Foghorn Therapeutics Inc. (FHTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Samuel Agresta's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Samuel Agresta has 5 Form 4 filings on record as an insider at Foghorn Therapeutics Inc..
Set alerts for Samuel Agresta and 40,000+ other insiders.